Why Moxifloxacin’s Approval for Plague Is So Disturbing
PLEASE SHARE YOUR OPINION AND VOTE BELOW On May 8th, 2015 moxifloxacin/Avelox was approved for treatment of inhalational plague.[1] We learn that the approval followed the ‘animal rule’ process, and that treatment with moxifloxacin was 100% effective in the African Green Monkey (AGM) model of lung infection. By contrast, 0% of Continue reading Why Moxifloxacin’s Approval for Plague Is So Disturbing